Rasburicase: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Rasburicase. Educational only — not medical advice.
Labeled uses
Elitek is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anticancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid.
Source: FDA labeling via NIH DailyMed (set 0ae10bc4…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.